Evidence map›Paper›PMID 35220153›Full record

ArticleAddictive behaviors2022

Intention to purchase alternative tobacco products as a function of smoking status and responses to advertising, packaging, and sensory experiences.

Akshika Sharma, Kristie M June, Kaila J Norton, Brian Fix, Maansi Bansal-Travers, Vaughan W Rees, Richard J O'Connor

Open access · greenAbstract read
In one paragraph

Article in Addictive behaviors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Likelihood of Purchasing E-cigarettes Among Adolescents and Young Adults Exposed to E-cigarette Retail Marketing Characteristics: A Cross-Sectional Survey.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Akshika SharmaDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, United States. Electronic address: Akshika.sharma@roswellpark.org.
Kristie M JuneDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, United States. Electronic address: Kristie.kibby@roswellpark.org.
Kaila J NortonDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, United States; Center for Tobacco Research, Ohio State University Comprehensive Cancer Center, United States. Electronic address: Kaila.norton@osumc.edu.
Brian FixDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, United States. Electronic address: Brian.fix@roswellpark.org.
Maansi Bansal-TraversDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, United States. Electronic address: Maansi.travers@roswellpark.org.
Vaughan W ReesDepartment of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, United States. Electronic address: vrees@hsph.harvard.edu.
Richard J O'ConnorDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, United States. Electronic address: Richard.Oconnor@roswellpark.org.
Roswell Park Comprehensive Cancer Center · USHarvard University · US

Funding

WNY Center for Research on Flavored Tobacco Products (CRoFT)U54CA228110 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI OSSIP, DEBORAH J · 2018 to 2022
$19.8M
Tobacco Constituent and Biomarker Assessment CoreU19CA157345 · NCI · UNIVERSITY OF MINNESOTA · PI HATSUKAMI, DOROTHY K, SHIELDS, PETER G. · 2012 to 2016
$13.3M
Project 4: Effects of cigarette filter ventilation on cigarette appeal and preferences for combusted and noncombusted tobacco productsP01CA217806 · NCI · UNIVERSITY OF MINNESOTA · PI HATSUKAMI, DOROTHY K, SHIELDS, PETER G. · 2017 to 2022
$12.6M
NCI NIH HHS P01 CA217806NCI NIH HHS U19 CA157345NCI NIH HHS U54 CA228110
6 · The paper itself

Abstract

introductionTobacco manufacturers design and marketed products with appealing sensory characteristics to drive product uptake and continued use. We assessed smokers' and non-smokers' cognitive, affective, and sensory responses to Camel Snus (CS) and Nicotine gum (NG) to gauge future intentions to use.

methodIn a single laboratory session, 348 participants (including current smokers and nonsmokers in Buffalo, NY and Boston, MA) were exposed to CS and NG products in counterbalanced order. Exposure involved a cumulative set of 3 steps in which participants i) viewed an advertisement; ii) viewed the packaging, and iii) touched and smelled the product, without actual use. Current daily and non-daily smokers were invited to undertake a fourth exposure step by sampling the product. Following product exposure, participants completed perception measures and reported future intentions to use either product at the end of the survey. After each exposure, participants' reported feelings of valence and arousal.

resultsSmokers reported greater preference to try NG (63.8%) compared with CS (17.4%) or neither (18.8%), whereas majority of nonsmokers preferred neither product (64.3%) (p < 0.01). Of those offered to sample the products, 78.3% daily smokers and 68.4% non-daily smokers opted to sample. When asked about intentions to try, a greater proportion of smokers stated a preference to try NG over CS, as did the small number of nonsmokers who expressed a preference.

conclusionIntentions to try CS were low despite different levels of exposure to product, and this low product appeal and interest in use may translate to limited potential of CS to serve as a reduced harm product for smokers.

Indexed as

Tobacco ProductsTobacco, SmokelessAdvertisingHumansIntentionSmokersSmokingAdvertisingHarm reductionNicotinePackagingSmokelessTobacco

Identifiers

PMID35220153
PMCPMC9376882
OpenAlexW4212963078

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.